2.50
Hdl Handle:
http://hdl.handle.net/10755/165415
Category:
Abstract
Type:
Presentation
Title:
Effects of the Neutropenic Diet in the Outpatient Setting
Author(s):
DeMille, D.; Fortenbaugh, C.; Lynch, M. P.; Deming, P.; Cappa, M.; Christian, A.
Author Details:
D. DeMille, Pennsylvania Hospital, Joan Karnell Cancer Center, Philadelphia, Pennsylvania, USA; C. Fortenbaugh; M. P. Lynch; P. Deming; M. Cappa; A. Christian
Abstract:
Chemotherapy patients are being instructed in the neutropenic diet based on past research involving a total protective environment. There have been no studies evaluating the effects of the neutropenic diet alone in the outpatient setting. This descriptive pilot study asks 3 questions: Are outpatients receiving chemotherapy able to comply with a neutropenic diet? Is there a difference in the number of febrile admissions between compliant versus non-compliant patients? Is there a difference in the number of positive blood cultures between compliant versus non-compliant patients? Patients between 18 and 70 years old, receiving outpatient chemotherapy are recruited from the Pennsylvania Hospital Joan Karnell Cancer Center and Pennsylvania Oncology and Hematology Associates. Enrollment is 12 weeks starting day 1 of cycle 1. Patients are instructed in the neutropenic diet before starting chemotherapy. Compliance assessment telephone calls are made at weeks 6 and 12. Hospital admission charts are reviewed at study completion. This study’s neutropenic diet is based on a 120 institution survey by Smith and Besser. The evaluation tool measures dietary compliance through target questions about food safety and diet restrictions utilizing the Likert scale. Admission, blood culture events and patient perception of compliance are questioned. The content validity was established through review of the tool by a multi-disciplinary team. Descriptive statistics will be used to address the first question. Occurrence of compliance within the sample will be analyzed as both raw and frequency data. Sample demographic data will be analyzed descriptively using mean, median, mode, and standard deviation calculations. Inferential statistics will be used to address the second and third questions. T-test analysis with a p value of 0.05 will be used to determine statistically significant differences in mean number of febrile admissions and positive blood cultures between subjects who are compliant versus non-compliant. Statistically significant differences will be reported as trends for guiding future design of a broader, randomized clinical trial. Health care professionals may change dietary education based on compliance and outcome information from this study. 16 patients have been enrolled to date. The study will be completed by November 1, 2002.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2003
Conference Name:
28th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Denver, Colorado, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleEffects of the Neutropenic Diet in the Outpatient Settingen_GB
dc.contributor.authorDeMille, D.en_US
dc.contributor.authorFortenbaugh, C.en_US
dc.contributor.authorLynch, M. P.en_US
dc.contributor.authorDeming, P.en_US
dc.contributor.authorCappa, M.en_US
dc.contributor.authorChristian, A.en_US
dc.author.detailsD. DeMille, Pennsylvania Hospital, Joan Karnell Cancer Center, Philadelphia, Pennsylvania, USA; C. Fortenbaugh; M. P. Lynch; P. Deming; M. Cappa; A. Christianen_US
dc.identifier.urihttp://hdl.handle.net/10755/165415-
dc.description.abstractChemotherapy patients are being instructed in the neutropenic diet based on past research involving a total protective environment. There have been no studies evaluating the effects of the neutropenic diet alone in the outpatient setting. This descriptive pilot study asks 3 questions: Are outpatients receiving chemotherapy able to comply with a neutropenic diet? Is there a difference in the number of febrile admissions between compliant versus non-compliant patients? Is there a difference in the number of positive blood cultures between compliant versus non-compliant patients? Patients between 18 and 70 years old, receiving outpatient chemotherapy are recruited from the Pennsylvania Hospital Joan Karnell Cancer Center and Pennsylvania Oncology and Hematology Associates. Enrollment is 12 weeks starting day 1 of cycle 1. Patients are instructed in the neutropenic diet before starting chemotherapy. Compliance assessment telephone calls are made at weeks 6 and 12. Hospital admission charts are reviewed at study completion. This study’s neutropenic diet is based on a 120 institution survey by Smith and Besser. The evaluation tool measures dietary compliance through target questions about food safety and diet restrictions utilizing the Likert scale. Admission, blood culture events and patient perception of compliance are questioned. The content validity was established through review of the tool by a multi-disciplinary team. Descriptive statistics will be used to address the first question. Occurrence of compliance within the sample will be analyzed as both raw and frequency data. Sample demographic data will be analyzed descriptively using mean, median, mode, and standard deviation calculations. Inferential statistics will be used to address the second and third questions. T-test analysis with a p value of 0.05 will be used to determine statistically significant differences in mean number of febrile admissions and positive blood cultures between subjects who are compliant versus non-compliant. Statistically significant differences will be reported as trends for guiding future design of a broader, randomized clinical trial. Health care professionals may change dietary education based on compliance and outcome information from this study. 16 patients have been enrolled to date. The study will be completed by November 1, 2002.en_GB
dc.date.available2011-10-27T12:18:08Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:18:08Z-
dc.conference.date2003en_US
dc.conference.name28th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationDenver, Colorado, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.